2331 related articles for article (PubMed ID: 29655688)
1. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
2. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
[TBL] [Abstract][Full Text] [Related]
5. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
[TBL] [Abstract][Full Text] [Related]
6. Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad- and epithelial-mesenchymal transition signaling pathways.
Liu SF; Chang SY; Lee TC; Chuang LY; Guh JY; Hung CY; Hung TJ; Hung YJ; Chen PY; Hsieh PF; Yang YL
PLoS One; 2012; 7(11):e47482. PubMed ID: 23144821
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
[TBL] [Abstract][Full Text] [Related]
8. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
11. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.
Zhang W; Song S; Liu F; Liu Y; Zhang Y
Peptides; 2015 Aug; 70():37-44. PubMed ID: 25882007
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated P311 inhibits TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells via TGF-β1-Smad-ILK pathway.
Qi F; Cai P; Liu X; Peng M; Si G
Biosci Trends; 2015 Oct; 9(5):299-306. PubMed ID: 26559022
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ
J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
16. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
17. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
[TBL] [Abstract][Full Text] [Related]
18. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.
Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ
J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of TGF-β1 induced tubular epithelial-mesenchymal transition via the δ-opioid receptor.
Luo F; Xu R; Song G; Xue D; He X; Xia Y
FEBS J; 2021 Feb; 288(4):1243-1258. PubMed ID: 32563195
[TBL] [Abstract][Full Text] [Related]
20. Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells.
Yang Z; Zhan YW; Huang YY; Huang W; Zhan F; Lin SD
J Biol Regul Homeost Agents; 2020; 34(1):57-67. PubMed ID: 32466632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
